SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹59 Cr | ₹54 Cr | ₹47 Cr | ₹33 Cr | ₹14 Cr |
What is the latest Total Current Liabilities ratio of SAKAR HEALTHCARE ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹59 Cr |
Mar2023 | ₹54 Cr |
Mar2022 | ₹47 Cr |
Mar2021 | ₹33 Cr |
Mar2020 | ₹14 Cr |
How is Total Current Liabilities of SAKAR HEALTHCARE Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹59 Cr | 8.38 | |
Mar2023 | ₹54 Cr | 16.50 | |
Mar2022 | ₹47 Cr | 40.60 | |
Mar2021 | ₹33 Cr | 135.08 | |
Mar2020 | ₹14 Cr | - |
Compare Total Current Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹782.9 Cr | -3% | 11.6% | 14.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,320.0 Cr | 0.9% | -0.1% | 10.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,823.0 Cr | 3.7% | 3% | 46.5% | Stock Analytics | |
CIPLA | ₹121,591.0 Cr | 0.2% | 2.8% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,400.0 Cr | 7.3% | 7.4% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,135.0 Cr | -4% | 2.6% | 7.2% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -3% |
11.6% |
14.6% |
SENSEX | 2.1% |
2.4% |
7.1% |
You may also like the below Video Courses